Evidence map›Paper›PMID 41832371›Full record

ArticleCardiovascular and interventional radiology2026

Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Portal Vein Recanalization in Cirrhotic Patients with Acute Portal Vein Thrombosis: A Single-Center Study.

Vijay Ramalingam, Zohaa Faiz, Mariam Dogar, Jeffrey Weinstein, Lauren Yang, Jonathan Berry, Michael Curry, Ammar Sarwar, Muneeb Ahmed

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vijay RamalingamDivision of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States. vramali1@bidmc.harvard.edu.ORCID http://orcid.org/0000-0003-4590-6466
Zohaa FaizDivision of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Mariam DogarHarvard Medical School, Boston, MA, United States.
Jeffrey WeinsteinDivision of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Lauren YangDivision of Hepatology, Department of Gastroenterology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Jonathan BerryDivision of Hepatology, Department of Gastroenterology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Michael CurryDivision of Hepatology, Department of Gastroenterology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Ammar SarwarDivision of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.
Muneeb AhmedDivision of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to evaluate the safety and effectiveness of TIPS-PVR in patients with cirrhosis with acute PVT. MATERIALS AND

methodsA retrospective analysis of cirrhotic patients with acute PVT who underwent TIPS-PVR at a single academic institution. Patients were categorized by PVT etiology and thrombus extent according to AASLD criteria. Outcomes assessed included technical success, one-year patency of the TIPS and porto-mesenteric venous system, need for TIPS reintervention, symptom recurrence, and overall survival. Overall survival was defined as the time from TIPS-PVR to death or last follow-up.

resultsFifty cirrhotic patients underwent TIPS-PVR for acute PVT. Technical success was 100%. Superior mesenteric vein (SMV) involvement was seen in 30/50 (60%), and splenic vein in 11/50 (22%). At one year, 32 patients had follow-up. Primary patency was 75% (24/32), primary-assisted patency 94% (30/32) for TIPS and 97% (31/32) for the portal vein. Patency rates improved at one year: Main portal vein from 18 to 97% (p < 0.001), SMV from 50 to 91% (p < 0.001), splenic vein from 78 to 100% (p = 0.0108). 9 patients underwent liver transplantation after TIPS-PVR. There were no grade 4 or grade 5 CIRSE adverse events. There were five Grade 6 events after the procedure. Overall survival was 78% at 12 months, with 95% CI 64-87%.

conclusionsTIPS-PVR appears to be a safe and effective procedure for cirrhotic patients with acute PVT, offering a viable option for restoring portal venous flow.

Indexed as

Liver CirrhosisPortal VeinPortasystemic Shunt, Transjugular IntrahepaticVenous ThrombosisAcute DiseaseAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeVascular PatencyCirrhosisPortal hypertensionPortal vein thrombosisTIPS-PVRTransjugular intrahepatic portosystemic shunt

Identifiers

PMID41832371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.